drugset / Trial / NCT01220622
Efficacy and Safety Study of Nimodipine to Prevent Mild Cognitive Impairment After Acute Ischemic Strokes
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The trial was designed to test the hypothesis that early treatment with nimodipine has a positive effect on cognition impairment after acute ischemic stroke.
Timeline
- Start
- 2010-10
- Primary completion
- 2012-04
- Completion
- 2012-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Nimodipine | Small molecule | 30 mg | — |